| Issue/Date |
Publications |
| N/A |
These will now be included with in the Medicines Optimisation monthly Newsletter |
| Issue 34 - Jul 22 |
- Topiramate and known harms if used in pregnancy
- New national safety review of topiramate
- Further details on the findings of the new study
- Topiramate and current pregnancy prevention requirements
- Advice on contraceptive interactions
- Valproate: current strict restrictions
- Medicines and Pregnancy Registry
- Report suspected reactions on a Yellow Card
|
| Issue 33 - 28/04/22 |
- Amiodarone (Cordarone X): reminder of risks of treatment and need for patient monitoring and supervision
- Metformin in pregnancy: study shows no safety concerns
- Cladribine (Mavenclad): new advice to minimise risk of serious liver injury – HOSPITAL ONLY
- COVID-19 vaccines and medicines: updates for March 2022
- Letters and medicine recalls sent to healthcare professionals in February 2022
|
| Issue 32 -24/03/22 |
- Hydroxychloroquine, chloroquine: increased risk of cardiovascular events when used with macrolide antibiotics; reminder of psychiatric reactions
- COVID-19 antivirals: reporting to the UK COVID-19 Antivirals Pregnancy Registry
- COVID-19 vaccines and medicines: updates for February 2022
- Letters and medicine recalls sent to healthcare professionals in January 2022
|
